City
Epaper

More pharma companies should be allowed to produce COVID-19 vaccines: Nitin Gadkari

By ANI | Updated: May 19, 2021 11:10 IST

Union Minister Nitin Gadkari on Tuesday said that more pharma companies should be allowed to manufacture the COVID-19 vaccine in the country during the pandemic to scale up production.

Open in App

Union Minister Nitin Gadkari on Tuesday said that more pharma companies should be allowed to manufacture the COVID-19 vaccine in the country during the pandemic to scale up production.

While addressing a meeting via video conferencing Gadkari said, "If the demand of vaccine is more than the supply, it creates the problem. So, instead of one company, let 10 more companies be given the license to manufacture the vaccine."

"There are 2-3 laboratories in every state. They should be given the formula to produce the COVID-19 vaccines. They can give royalty," Gadkari said.

"Let them supply in the country and later if there is surplus, they may export. It can be done in 15-20 days," he added.

Currently, only two firms - Bharat Biotech and Serum Institute of India - are manufacturing COVID vaccines in the country and only three vaccines have so far been approved to be sold in India --- COVAXIN, COVESHIELD and Sputnik V.

Many states have complained about the shortage of COVID-19 vaccines.

Reacting to Gadkari's comment on the shortage of the COVID-19 vaccines, national spokesperson of Congress Jaiveer Shergill said that the whole nation is demanding vaccines, BJP is supplying fake tool kits.

"Mr Gadkari says to solve Vaccine demand-supply issue more manufacturing licenses should be given. The problem is-Nation is demanding vaccines, BJP is supplying fake tool kits. Good to know at least one BJP minister is waking up to reality - how many more have to die to wake up the system," Shergill tweeted.

A total of 18,58,09,302 doses of COVID-19 vaccines have been administered across the country since the vaccination drive began on January 16.

According to official data, 2,67,334 fresh COVID-19 cases were recorded during a 24-hour period.

"The cumulative caseload stands at 2,54,96,330, including 32,26,719 active cases, 2,19,86,363 recoveries and 2,83,248 deaths," the Union Health Ministry said.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat biotech and serum institute of indiacongressNitin GadkariShri nitin gadkari
Open in App

Related Stories

MaharashtraPolice Deployed at Carnac Bridge as Shiv Sena (UBT) and MNS Threaten Protest Over Delay in Reopening

NationalToll Tax for Two-Wheelers on National Highways? NHAI and Nitin Gadkari Issues Clarification

NationalAssembly Bypoll Results 2025: AAP Wins Visavadar and Ludhiana West Seats; Congress Wrests Nilambur Seat in Kerala

NationalNew Two-Wheeler Rules: ABS and Two Helmets to be Mandatory for All New Two-Wheelers from 2026; Centre’s Big Move to Curb Road Accidents

National“I Have Disagreements With Congress Leadership”: Shashi Tharoor Says Party Did Not Invite Him for Nilambur Byelection Campaign

National Realted Stories

NationalSC Collegium recommends appointments in nine different HCs

NationalInternal reservation: Row erupts over survey households in Karnataka, three staffers suspended

NationalTripura no longer a safe zone for infiltrators, says CM Saha

NationalGovt will take a positive decision on problems of farmers, labourers: Maha Minister

National'Free electricty and free water can't continue for long': Rajasthan BJP chief Madan Rathore